Humacyte (HUMA) Margins & Profitability 2020-2026
Gross, EBITDA, operating, and net margin trends
Margins
Profit margins across the income statement
- EBITDA Margin
- -6320.0%
- Op. Margin
- -6649.3% 32.7%
- Net Margin
- -9064.5% 27.5%
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit